{"filing":{"accession_number":"0001171843-26-003793","cik":"0001540159","ticker":"EDSA","company_name":"Edesa Biotech, Inc.","form":"8-K","filing_date":"2026-05-29","report_date":null,"primary_document":"f8k_052226.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003793/f8k_052226.htm"},"events":[{"id":8076,"run_id":7091,"accession_number":"0001171843-26-003793","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Edesa Biotech held an Annual Meeting of shareholders on which four proposals were voted: election of seven directors, advisory vote on executive compensation, approval of an amendment to the 2019 Equity Incentive Compensation Plan increasing available shares by 750,000 and eliminating annual per-participant option grant limits, and appointment of MNP LLP as auditors. All proposals passed with substantial majorities.","company_name":"Edesa Biotech, Inc.","ticker":"EDSA","filing_date":"2026-05-29","form":"8-K","submitted_at":null,"items":[{"id":2647,"accession_number":"0001171843-26-003793","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors;","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on shareholder approval of an amendment to the 2019 Equity Incentive Compensation Plan that increases available shares by 750,000 and eliminates annual per-participant option grant limits. This is a material compensatory arrangement amendment affecting the pool of equity available for executive and employee compensation, directly within the scope of Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:09:09.948415+00:00","company_name":"","ticker":null,"filing_date":""},{"id":2648,"accession_number":"0001171843-26-003793","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from an Annual Meeting. The filing reports voting outcomes on four proposals: election of seven directors, advisory vote on executive compensation, approval of an amendment to the 2019 Equity Incentive Compensation Plan, and appointment of MNP LLP as auditors. All proposals passed with substantial majorities, and the disclosure includes vote tallies (For/Against/Withhold/Abstain/Broker Non-Votes) for each matter as required by Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:09:09.948415+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2647,"accession_number":"0001171843-26-003793","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors;","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on shareholder approval of an amendment to the 2019 Equity Incentive Compensation Plan that increases available shares by 750,000 and eliminates annual per-participant option grant limits. This is a material compensatory arrangement amendment affecting the pool of equity available for executive and employee compensation, directly within the scope of Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:09:09.948415+00:00","company_name":"Edesa Biotech, Inc.","ticker":"EDSA","filing_date":"2026-05-29"},{"id":2648,"accession_number":"0001171843-26-003793","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from an Annual Meeting. The filing reports voting outcomes on four proposals: election of seven directors, advisory vote on executive compensation, approval of an amendment to the 2019 Equity Incentive Compensation Plan, and appointment of MNP LLP as auditors. All proposals passed with substantial majorities, and the disclosure includes vote tallies (For/Against/Withhold/Abstain/Broker Non-Votes) for each matter as required by Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:09:09.948415+00:00","company_name":"Edesa Biotech, Inc.","ticker":"EDSA","filing_date":"2026-05-29"}]}